Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects

Anti-obesity drugs in the amphetamine (AMPH) class act in the brain to reduce appetite and increase locomotion. They are also characterized by adverse cardiovascular effects with origin that, despite absence of any in vivo evidence, is attributed to a direct sympathomimetic action in the heart. Here...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cell Metab
Main Authors: Mahú, Inês, Barateiro, Andreia, Rial-Pensado, Eva, Martinéz-Sánchez, Noelia, Vaz, Sandra H., Cal, Pedro M.S.D., Jenkins, Benjamin, Rodrigues, Tiago, Cordeiro, Carlos, Costa, Miguel F., Mendes, Raquel, Seixas, Elsa, Pereira, Mafalda M.A., Kubasova, Nadiya, Gres, Vitka, Morris, Imogen, Temporão, Carolina, Olivares, Marta, Sanz, Yolanda, Koulman, Albert, Corzana, Francisco, Sebastião, Ana M., López, Miguel, Bernardes, Gonçalo J.L., Domingos, Ana I.
פורמט: Artigo
שפה:Inglês
יצא לאור: Cell Press 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7671941/
https://ncbi.nlm.nih.gov/pubmed/32402266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2020.04.013
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים